Neos Therapeutics, Inc. (NEOS) relating to its proposed merger with Aytu BioScience, Inc. Under the terms of the agreement, NEOS shareholders will receive 0.1088 shares of Aytu per share they own.
Neos Therapeutics, Inc. (NEOS) relating to its proposed merger with Aytu BioScience, Inc. Under the terms of the agreement, NEOS shareholders will receive 0.1088 shares of Aytu per share they own.